{
    "nctId": "NCT05445050",
    "briefTitle": "mULM to Support Breast Cancer Diagnosis and Therapy",
    "officialTitle": "Development of Motion-Model Ultrasound Localization Microscopy to Support Breast Cancer Diagnosis and Therapy Monitoring in Patients",
    "overallStatus": "RECRUITING",
    "conditions": "Primary Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 74,
    "primaryOutcomeMeasure": "Relative blood volume",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* written informed consent\n* age \u2265 18 yrs\n* histologically confirmed primary breast cancer including all intrinsic subtypes (study parts A and B)\n* highly suspected primary breast cancer (study part C)\n* treatment with neoadjuvant chemotherapy (study part B)\n* persons who are legally competent and mentally able to follow the instructions of the study team\n\nExclusion Criteria:\n\n* younger than 18 years\n* hypersensitivity / allergy to sulfur hexafluoride, Macrogol 4000, distearoylphosphatidylcholine, dipalmitoylphosphatidylglycerol-sodium, palmitic acid\n* right-left shunt,\n* signs of cardiovascular instability\n* acute endocarditis\n* artificial heart valves\n* acute systemic inflammation and/or sepsis\n* overactive coagulation status and/or recent thromboembolic events\n* end stage of liver and kidney diseases\n* severe pulmonary hypertension (pulmonary arterial pressure \\> 90 mmHg)\n* uncontrolled systemic hypertension\n* acute respiratory distress syndrome\n* pregnancy\n* commitment of the patient to any resident institution by order of any court or authority\n* expectation of missing compliance\n* alcohol or drug abuse\n* patients who are in a relationship of dependence or in a working relationship to the sponsor, the investigator or his representative",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}